Navigation Links
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Date:11/28/2008

ieved to potentiate the activity of these chemicals in the central nervous system (brain and spinal cord). While the exact mechanism of action of Duloxetine is unknown, scientists believe its effects on depression and anxiety symptoms, as well as its effect on pain perception, may be due to increasing the activity of serotonin and norepinephrine in the central nervous system.

Duloxetine is approved in the United States for the acute and maintenance treatment of major depressive disorder, the acute treatment of generalized anxiety disorder, and the management of diabetic peripheral neuropathic pain and fibromyalgia in adults age 18 years and older. Duloxetine is not approved for use in pediatric patients.

Important Safety Information

Duloxetine is approved to treat major depressive disorder and generalized anxiety disorder, and to manage diabetic peripheral neuropathic pain and fibromyalgia. Antidepressants can increase suicidal thoughts and behaviors in children, adolescents, and young adults. Patients should call their doctor right away if they experience new or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Duloxetine is approved only for adults 18 and over.

Duloxetine is not for everyone. Patients should not take Duloxetine if they have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI), are taking Mellaril(R) (thioridazine), or have uncontrolled glaucoma. Patients should speak with their doctor about any medical conditions they may have including kidney problems, glaucoma, or diabetes. Patients should talk to their doctor if they have itching, right upper belly pain, dark urine, yellow skin or eyes, or unexplained flu-like symptoms, which may be signs of liver problems. Severe liver problems, sometimes fatal, have been repor
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
2. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
3. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Lilly and TransPharma Medical Announce Licensing and Development Agreement
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
10. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
11. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
(Date:2/26/2015)... 2015 Every year many millions of donations ... disease.  Nevertheless, year after year doctors and the medical ... first test to determine the status of heart health ... not, even though that technology is over 100 years ... doctors know, (while most patients do not know) that ...
(Date:2/26/2015)... DUBLIN , Feb. 26, 2015 Research and ... addition of the "Radiation Therapy Equipment - Global ... This report analyzes the worldwide markets for ... Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation ... the US, Canada , ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2National Heart Health Month In February 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... MOUNT PROSPECT, Ill., June 6, 2011 As part ... reducing abuse, misuse, and diversion of prescription medications, the ... development of the NABP PMP InterConnect. NABP will now ... (PMP) administrators and their software vendors to finalize the ...
... 2011 Cantel Medical Corp. (NYSE: CMN ... CEO of its Minntech Corporation subsidiary, sustained serious injuries ... Saturday evening. Mr. Malkin,s condition is currently ... Mr. Malkin,s treatment and recovery, division heads at Minntech ...
Cached Medicine Technology:NABP PMP InterConnect Development Complete; PMPs Continue to Sign on to Participate in National System for Tracking Drug Abuse and Diversion 2
(Date:2/27/2015)... February 27, 2015 Victorian Hotel recently ... for couples who wanted to spend the auspicious day ... to get a jump on Valentine’s Day with a ... in one of their luxurious rooms. , The ... inviting guests for a mouthwatering 3 course meal at ...
(Date:2/27/2015)... 2015 Mediaplanet today announces the launch ... campaign that aims to bring blood health and cancer ... The stories in this edition go beyond the concept ... care, hard-hitting advocacy, research and technological strides needed to ... American Cancer Society, approximately every 3 minutes one ...
(Date:2/27/2015)... The Nashville periodontist office, Advanced Institute ... freshmen undergraduate students. , The Advanced Institute for Oral ... periodontal procedures such as dental implants , ... In honor of their 25th anniversary, AIOH has announced ... undergraduate students. , Students interested in the scholarship ...
(Date:2/27/2015)... February 27, 2015 Insight Accelerator ... to advance the development of an in-line urine ... solution is being developed in direct response to ... 73% accuracy and error margins with potentially grave ... output measurement and provide trending data analysis to ...
(Date:2/27/2015)... Mirena IUD lawsuits ( http://www.mirenalawsuit2014.com/ ) ... perforations and other serious harm due to spontaneous migration ... in the multicounty litigation underway in New Jersey’s Bergen ... records indicate that the proceeding’s 34th Case Management Order ... that same day. (In Re: Mirena Litigation; Case No. ...
Breaking Medicine News(10 mins):Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3
... Biomoda, Inc.,(OTC Bulletin Board: BMOD) ( http://www.biomoda.com ... intellectual property portfolio,with approval from the U.S. Patent ... "We are pleased to receive these two ... John Cousins, Biomoda president. "It is a big,milestone ...
... Organizations and Individuals Need to Enhance Computer Security, ... the market,s,leading Security-as-a-Service (SaaS) providers, has published the ... of cyber attacks were,attempted against its clients in ... million attempted attacks originating from computers within the,country ...
... 2008 A study appearing in the Sept. 18 ... shows that among individuals with no colorectal neoplasia (abnormal growths) ... is extremely low. The data provides support for rescreening at ... colonoscopic examination. , "This research is very significant as it ...
... curcumin part of your daily diet. , This ... only lowers your chances of getting cancer and Alzheimer,s ... stroke, say Medical College of Georgia researchers. , Second-year ... Dhandapani, neuroscientist in the MCG School of Medicine, using ...
... radiosurgery (SRS) and whole brain radiation therapy (WBRT) for ... twice the risk of developing learning and memory problems ... research from The University of Texas M. D. Anderson ... randomized trial were presented at today,s 50th annual meeting ...
... of America Honors Michael R. Bristow, M.D., Ph.D., ... Society of America,(HFSA) announced today that Michael Bristow, ... of the University of Colorado,Cardiovascular Institute, is the ... award was presented to Bristow at the Opening,Plenary ...
Cached Medicine News:Health News:U.S. Patent Office Grants Biomoda Registration for Trademarks 2Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 2Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 3Health News:Risk of colorectal cancer extremely low 5 years after a normal colonoscopy screening 2Health News:Indian spice reduces size of hemorrhagic stroke 2Health News:Whole brain radiation increases risk of learning and memory problems in cancer patients 2Health News:Whole brain radiation increases risk of learning and memory problems in cancer patients 3Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 2Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 3
... CMC joint is the most common site for ... the CMC joint without restricting the wrist or ... persons who need to control or reduce subluxation ... perform work and leisure activities without pain. Also ...
... This is an excellent choice to treat ... MCP joint, basal joint arthritis, advanced carpal ... the thumb and wrist. Distal palmar ... flexion and full finger dexterity. Constructed ...
... CTi Wrist OTS is an off-the-shelf wrist orthotic designed ... of 3 pre-set ranges-of-motion (20°,35° and 50°). , ... sprains with TFCC tear-triangular fibrocartilage complex , ... nonunion , Partial tendon rupture , ...
... CTi Wrist Static is a solid, one-piece custom wrist ... stable, neutral position. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
Medicine Products: